Earth Science Tech Inc. has announced a strategic directive to reinforce its identity as a pharmaceutical entity, following its transition to the healthcare and pharmaceutical sectors. The company is instructing all financial data providers, news aggregators, and brokerage platforms to update their records to reflect its official SEC-registered classification under SIC 2834 (Pharmaceutical Preparations). ETST is actively engaging with major data desks, including Bloomberg, Morningstar, and S&P Global, to ensure that its industry classification is permanently updated across all financial platforms. The company’s operational focus includes pharmaceutical compounding through its subsidiaries and the management of telemedicine infrastructure to support the clinical delivery of its pharmaceutical products. These actions are aimed at aligning the company’s market representation with its current business activities in the pharmaceutical sector.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Earth Science Tech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-000511), on January 06, 2026, and is solely responsible for the information contained therein.